Nuzenio

Bitget Protagonist Therapeutics

Bitget Protagonist Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 17:31:58 GMTPROTAGONIST THERAPEUTICS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $167 FROM $117 - Bitget
Thu, 06 Aug 2026 16:28:09 GMTSUNCOR ENERGY INC (CANADA) : RAYMOND JAMES RAISES TARGET PRICE TO C$109 FROM C$103 - Bitget
Thu, 06 Aug 2026 16:16:59 GMTPROTAGONIST THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $150.00 FROM $110.00 - Bitget
Thu, 06 Aug 2026 03:00:33 GMTOil prices slip as Iran-Oman talks fuel hopes for US-Iran peace deal - Bitget
Thu, 06 Aug 2026 02:13:33 GMTPROTAGONIST THERAPEUTICS, INC. : CITIGROUP RAISES TARGET PRICE TO $175 FROM $130 - Bitget
Wed, 05 Aug 2026 23:09:11 GMTTenaris 2Q FY26 shareholders’ net income drops 10% to $477 million; net sales fall 4% to $2.97 billion vs 2Q FY25 - Bitget

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Bitget Protagonist Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.